24 related articles for article (PubMed ID: 30380446)
1. Photoisomerization and Light-Controlled Antibacterial Activity of Fluoroquinolone-Azoisoxazole Hybrids.
Dolai A; Bhunia S; Jana SK; Bera S; Mandal S; Samanta S
Chembiochem; 2024 Apr; 25(8):e202300851. PubMed ID: 38409655
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of antifungal drugs in the treatment of vulvovaginal candidiasis: a Bayesian network meta-analysis.
Qin F; Wang Q; Zhang C; Fang C; Zhang L; Chen H; Zhang M; Cheng F
Infect Drug Resist; 2018; 11():1893-1901. PubMed ID: 30425538
[TBL] [Abstract][Full Text] [Related]
3. A survey of isatin hybrids and their biological properties.
Shu VA; Eni DB; Ntie-Kang F
Mol Divers; 2024 Jun; ():. PubMed ID: 38833124
[TBL] [Abstract][Full Text] [Related]
4. Fluoroquinolones' Biological Activities against Laboratory Microbes and Cancer Cell Lines.
Suaifan GARY; Mohammed AAM; Alkhawaja BA
Molecules; 2022 Mar; 27(5):. PubMed ID: 35268759
[TBL] [Abstract][Full Text] [Related]
5. Recent Advances in the Synthesis and Biological Activity of 8-Hydroxyquinolines.
Saadeh HA; Sweidan KA; Mubarak MS
Molecules; 2020 Sep; 25(18):. PubMed ID: 32967141
[TBL] [Abstract][Full Text] [Related]
6. Recent updates of fluoroquinolones as antibacterial agents.
Ezelarab HAA; Abbas SH; Hassan HA; Abuo-Rahma GEA
Arch Pharm (Weinheim); 2018 Sep; 351(9):e1800141. PubMed ID: 30048015
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Chlamydia trachomatis Growth During the Last Decade: A Mini-Review.
Serradji N; Vu TH; Kim H; Panyam J; Verbeke P
Mini Rev Med Chem; 2018; 18(16):1363-1372. PubMed ID: 29692244
[TBL] [Abstract][Full Text] [Related]
8. Modified Fluoroquinolones as Antimicrobial Compounds Targeting
Vu TH; Adhel E; Vielfort K; Ha Duong NT; Anquetin G; Jeannot K; Verbeke P; Hjalmar S; Gylfe Å; Serradji N
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743189
[No Abstract] [Full Text] [Related]
9. N-substituted piperazinyl sarafloxacin derivatives: synthesis and in vitro antibacterial evaluation.
Asadipour A; Moshafi MH; Khosravani L; Moghimi S; Amou E; Firoozpour L; Ilbeigi G; Beiki K; Soleimani E; Foroumadi A
Daru; 2018 Dec; 26(2):199-207. PubMed ID: 30392156
[TBL] [Abstract][Full Text] [Related]
10. Preparation and antibacterial evaluation of decarboxylated fluoroquinolones.
Nguyen ST; Ding X; Butler MM; Tashjian TF; Peet NP; Bowlin TL
Bioorg Med Chem Lett; 2011 Oct; 21(19):5961-3. PubMed ID: 21865042
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, antimycobacterial and antibacterial activity of fluoroquinolone derivatives containing an 3-alkoxyimino-4-(cyclopropylanimo)methylpyrrolidine moiety.
Zhang T; Shen W; Liu M; Zhang R; Wang M; Li L; Wang B; Guo H; Lu Y
Eur J Med Chem; 2015 Nov; 104():73-85. PubMed ID: 26435513
[TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of 3-isoxazolidone derivatives as new Chlamydia trachomatis inhibitors.
Abdelsayed S; Ha Duong NT; Hai J; Hémadi M; El Hage Chahine JM; Verbeke P; Serradji N
Bioorg Med Chem Lett; 2014 Aug; 24(16):3854-60. PubMed ID: 25027937
[TBL] [Abstract][Full Text] [Related]
13. In vitro activities of a new fluoroquinolone derivative highly active against Chlamydia trachomatis.
Vu TH; Ha-Duong NT; Aubry A; Capton E; Fechter P; Plésiat P; Verbeke P; Serradji N
Bioorg Chem; 2019 Mar; 83():180-185. PubMed ID: 30380446
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
